1 |
De Haas SL, Schoemaker RC, van Gerven JM, Hoever P, Cohen AF, Dingemanse J. Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjects. J Psychopharmacol 2010;24:1619-1629.
DOI
ScienceOn
|
2 |
Toner LC, Tsambiras BM, Catalano G, Catalano MC, Cooper DS. Central nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol 2000;23: 54-58.
DOI
ScienceOn
|
3 |
Brodeur MR, Stirling AL. Delirium associated with zolpidem. Ann Pharmacother 2001;35:1562-1564.
DOI
ScienceOn
|
4 |
Paradis CM, Siegel LA, Kleinman SB. Two cases of zolpidem- associated homicide. Prim Care Companion CNS Disord 2012;14. pii: PCC.12br01363.
|
5 |
Kang DY, Park S, Rhee CW, et al. Zolpidem use and risk of fracture in elderly insomnia patients. J Prev Med Public Health 2012;45:219-226.
DOI
ScienceOn
|
6 |
Kim YM, Lee SR, Jung JY, et al. Incidence and Risk Factors of Zolpidem-Induced Delirium. Korean J Med 2013;84: 804-809.
DOI
|
7 |
FDA requires lower dosing of zolpidem. Med Lett Drugs Ther 2013;55:5.
|
8 |
Kolla BP, Lovely JK, Mansukhani MP, Morgenthaler TI. Zolpidem is independently associated with increased risk of inpatient falls. J Hosp Med 2013;8:1-6.
DOI
ScienceOn
|